Reset Filters
Branch: 上海图书馆

Cover is for reference only

Whistleblowers incentives, disincentives, and protection strategies /

"The book will discuss business protection strategies and best practices in dealing with whistleblowers, as well as the GlaxoSmithKline, Pfizer and other high profile whistleblower cases. The book is expected to appeal to Board members, C-Suite executives, corporate compliance personnel, attorn...

Full description

Saved in:
Bibliographic Details
Main Authors: Lipman, Frederick D
Published:
Literature type: Electronic eBook
Language: English
Series: Wiley corporate F&A series
Subjects:
Whistle blowing > United States
Business ethics > United States
Whistle blowing > Law and legislation > United States
Whistle blowing > Case studies
BUSINESS & ECONOMICS / Business Ethics
Business ethics
Whistle blowing
Whistle blowing > Law and legislation
United States
Case studies
Electronic books
Online Access: http://onlinelibrary.wiley.com/book/10.1002/9781118386545
Summary: "The book will discuss business protection strategies and best practices in dealing with whistleblowers, as well as the GlaxoSmithKline, Pfizer and other high profile whistleblower cases. The book is expected to appeal to Board members, C-Suite executives, corporate compliance personnel, attorneys for whistleblowers and defense attorneys as well as all potential employee whistleblowers. The book emphasizes the disincentives to whistleblowing, and will review the academic studies of whistleblowers with the idea of developing best practices to deal with whistleblowers: Introduction. 1. Dodd-Fr
Carrier Form: 1 online resource (xv, 272 p.)
Bibliography: Includes bibliographical references and index.
ISBN: 9781118386545
111838654X
9781118168486
1118168488
Index Number: HD60
CLC: F279.11
Contents: Front Matter -- Introduction -- The Whistleblowers and the Dodd₆Frank Incentives. The Dramatic Expansion of Whistleblower Awards under Dodd₆Frank -- The Remarkable Story of Cheryl Eckard and the $96 Million Bounty under the False Claims Act -- The Pfizer Whistleblowers who Collected Over $100 Million under the False Claims Act -- Disincentives and Factors Motivating Public Disclosure. Disincentives to Internal Whistleblowers -- Women as Whistleblowers: Factors Motivating Public Whistleblowing -- Organizational Best Practices. Why Should Organizations Adopt a Robust Whistleblower System?

Related Book Recommendations